Twist Bioscience (TWST) Other Non-Current Assets (2018 - 2026)
Twist Bioscience has reported Other Non-Current Assets over the past 9 years, most recently at $5.4 million for Q1 2026.
- Quarterly Other Non-Current Assets rose 47.14% to $5.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.4 million through Mar 2026, up 47.14% year-over-year, with the annual reading at $4.9 million for FY2025, 74.08% up from the prior year.
- Other Non-Current Assets was $5.4 million for Q1 2026 at Twist Bioscience, up from $2.4 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $5.4 million in Q1 2026 and troughed at $1.6 million in Q1 2022.
- The 5-year median for Other Non-Current Assets is $2.8 million (2023), against an average of $3.1 million.
- Year-over-year, Other Non-Current Assets crashed 67.54% in 2022 and then surged 178.56% in 2023.
- A 5-year view of Other Non-Current Assets shows it stood at $2.4 million in 2022, then grew by 18.13% to $2.8 million in 2023, then rose by 21.0% to $3.4 million in 2024, then plummeted by 30.51% to $2.4 million in 2025, then surged by 126.98% to $5.4 million in 2026.
- Per Business Quant, the three most recent readings for TWST's Other Non-Current Assets are $5.4 million (Q1 2026), $2.4 million (Q4 2025), and $4.9 million (Q3 2025).